Ecolab Inc.
ECL Basic Materials Chemicals - Specialty NYSE
$259.69
$-4.73 (-1.79%)
Open: $264.76 | High: $264.98 | Low: $259.13 | Prev Close: $264.42
Market Cap: $73.62B
Volume: 1.5M | Avg: 1.5M
Last updated: December 05, 2025 at 10:01 PMInvestment Rating
Neutral
Overall Score: 60/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 345
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | 37.37 |
| P/B Ratio | 7.58 |
| P/S Ratio | 4.63 |
| EPS | $6.95 |
| Beta | 0.99 |
| Shares Outstanding | 283.47M |
| 52-Week High | $286.04 |
| 52-Week Low | $221.62 |
| SMA 50 | $268.25 |
| SMA 200 | $263.67 |
| Dividend Yield | 1.00% |
| Annual Dividend | $2.60 |
| Next Earnings | February 10, 2026 05:00 AM ET |
Financial Ratios
| Gross Margin | 44.3% |
| Operating Margin | 17.3% |
| Net Margin | 12.5% |
| ROE | 21.6% |
| ROA | 8.3% |
| Debt/Equity | 0.89 |
| Current Ratio | 1.70 |
| Quick Ratio | 1.33 |
Balance Sheet
| Total Assets | $22.39B |
| Total Liabilities | $13.60B |
| Total Equity | $8.76B |
| Cash | $1.26B |
| Total Debt | $8.28B |
| Net Debt | $7.03B |
Income Statement
| Revenue | $15.74B |
| Gross Profit | $6.84B |
| Operating Income | $2.61B |
| Net Income | $2.11B |
| EBITDA | $3.85B |
| Revenue/Share | $56.05 |
Cash Flow
| Operating CF | $2.81B |
| CapEx | $994.50M |
| Free Cash Flow | $1.82B |
| Book Value/Share | $34.41 |
| Tangible Book/Share | $-5.27 |
| Equity/Share | $34.28 |
Technical Indicators
| RSI (14) | 53.28 Neutral |
| MACD |
0.90
Signal: 0.29
|
| Volatility | 24.20% |
| Trading Signal | Bullish |
Performance & Returns
| 1 Year | -2.46% |
| Sharpe Ratio | -0.18 Poor |
| Volatility (Ann.) | 20.68% Moderate |
| ECL (1Y) | -2.46% |
| S&P 500 (1Y) | +11.86% |
| Alpha (Excess Return) | -14.32% |
Sector Comparison (Basic Materials)
| Metric | ECL | Sector Avg | Percentile |
|---|---|---|---|
| P/E Ratio | 37.37 | 0.53 | 95% |
| P/B Ratio | 7.58 | 3.34 | 90% |
| ROE (%) | 21.65% | 10.63% | 79% |
| Net Margin (%) | 12.49% | 7.95% | 68% |
| Stock Score | 345 | 471.0 | 11% |
| 1Y Return (%) | -2.46% | +0.10% | 58% |
Historical Price Analysis (Last 200 Days)
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ECL | $259.69 | $269.53 | $270.61 | $266.64 | $268.25 | $263.67 | 53.28 | 0.90 | 24.20% | 1672038 | Weak Short | Price Below SMAs |
Candlestick Patterns
There wasn't any recognizable pattern for the ECL stock
News Sentiment
| 📊 Ticker | 📰 Headline | 💭 Sentiment | 📡 Source | 🔗 URL |
|---|---|---|---|---|
| ECL | Ecolab Increases Cash Dividend 12% | Positive | businesswire.com | Read More |
| ECL | Ecolab Inc. $ECL Stock Holdings Lifted by Groupe la Francaise | Neutral | defenseworld.net | Read More |
| ECL | Ecolab Inc. $ECL Shares Purchased by Edgestream Partners L.P. | Neutral | defenseworld.net | Read More |
| ECL | Ecolab Inc. $ECL Position Lessened by Arrowstreet Capital Limited Partnership | Neutral | defenseworld.net | Read More |
| ECL | Here's Why You Should Retain Ecolab Stock in Your Portfolio Now | Neutral | zacks.com | Read More |
Company Information
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in Saint Paul, Minnesota.
| CEO | Christophe Beck |
| Employees | 48000 |
| Country | US |
| IPO Date | 1957-01-01 |
| Exchange | NYSE |
| Website | https://www.ecolab.com |
| Sector | Basic Materials |
| Industry | Chemicals - Specialty |
Similar Stocks (Basic Materials - Chemicals - Specialty)
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category